Celularity (CELU) Free Cash Flow (2019 - 2025)
Celularity (CELU) posted quarterly Free Cash Flow of -$5.1 million for Q4 2025, down 3502.0% year-over-year from $150000.0 in Q4 2024, and down 22.7% quarter-over-quarter from -$4.2 million in Q3 2025.
Celularity (CELU) Free Cash Flow (2019 - 2025) Analysis & Trends
Celularity (CELU) has reported Free Cash Flow for 7 consecutive years, with -$5.1 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Free Cash Flow fell 3502.0% year-over-year to -$5.1 million; the TTM figure through Dec 2025 stood at -$13.3 million (down 67.75% YoY), while the FY2025 annual figure was -$13.3 million, down 67.75% from the prior year.
- Free Cash Flow slipped to -$5.1 million in Q4 2025 per CELU's latest filing, from -$4.2 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $150000.0 in Q4 2024 and bottomed at -$39.3 million in Q3 2022.
- Historically, Free Cash Flow has averaged -$15.5 million across 5 years, with a median of -$9.8 million in 2023.
- Annual changes were most pronounced in 2021 — Free Cash Flow tumbled 7993.73% — and 2024, when it soared 103.05%.
- Celularity's Free Cash Flow stood at -$29.1 million in 2021, then gained by 11.35% to -$25.8 million in 2022, then jumped by 80.93% to -$4.9 million in 2023, then jumped by 103.05% to $150000.0 in 2024, then tumbled by 3502.0% to -$5.1 million in 2025.
- Business Quant data shows CELU's Free Cash Flow at -$5.1 million in Q4 2025, -$4.2 million in Q3 2025, and -$999000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -563.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 437.80 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 292.04 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 433.84 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -95.09 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 477.44 Mn |
| 10 | Celularity | 20.99 Mn | 14.82 Mn | -3.27 Mn | -5.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.10 Mn |
| Dec 31, 2025 | -5.10 Mn |
| Sep 30, 2025 | -4.16 Mn |
| Sep 30, 2025 | -4.16 Mn |
| Jun 30, 2025 | -999,000.00 |
| Jun 30, 2025 | -999,000.00 |
| Mar 31, 2025 | -2.99 Mn |
| Mar 31, 2025 | -2.99 Mn |
| Dec 31, 2024 | 150,000.00 |
| Dec 31, 2024 | 150,000.00 |
| Sep 30, 2024 | -130,000.00 |
| Sep 30, 2024 | -130,000.00 |
| Jun 30, 2024 | -3.48 Mn |
| Jun 30, 2024 | -3.48 Mn |
| Mar 31, 2024 | -4.44 Mn |
| Mar 31, 2024 | -4.44 Mn |
| Dec 31, 2023 | -4.92 Mn |
| Dec 31, 2023 | -4.92 Mn |
| Sep 30, 2023 | -7.78 Mn |
| Sep 30, 2023 | -7.78 Mn |